| Institution: | Ivan Berlin, M.D., Ph.D., is Associate Professor in Clinical Pharnmacology at the Pierre and Marie Curie University —Pitié-Salpêtrièe Medical School in Paris, France. He obtained his M.D. at Seminelweis University Medical School in Budapest, and he is board-certified in internal medicine. He obtained his Ph.D. in pharmacology and his Habilitation to Direct Research at the Pierre and Marie Curie University.;David A. Gorelick, M.D., Ph.D., is Chief, CI in ica 1 Pha rniacology Section, Intramural Research Prograin, National Institute o n Drug Abuse, National Institutes of Health in Baltimore, Maryland, and Adjunct Professor of Psychiatry at the University of Maryland School of Medicine. He obtained his M.D. and Ph.D. in pharmacology at the Albert Einstein College of Medicine in the Bronx, New York. |
